General Information of Drug Off-Target (DOT) (ID: OT39TA1L)

DOT Name Superoxide dismutase (SOD1)
Synonyms EC 1.15.1.1; Superoxide dismutase 1; hSod1
Gene Name SOD1
Related Disease
Amyotrophic lateral sclerosis type 1 ( )
Spastic tetraplegia and axial hypotonia, progressive ( )
Amyotrophic lateral sclerosis ( )
UniProt ID
SODC_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1AZV ; 1BA9 ; 1DSW ; 1FUN ; 1HL4 ; 1HL5 ; 1KMG ; 1L3N ; 1MFM ; 1N18 ; 1N19 ; 1OEZ ; 1OZT ; 1OZU ; 1P1V ; 1PTZ ; 1PU0 ; 1RK7 ; 1SOS ; 1SPD ; 1UXL ; 1UXM ; 2AF2 ; 2C9S ; 2C9U ; 2C9V ; 2GBT ; 2GBU ; 2GBV ; 2LU5 ; 2MP3 ; 2NAM ; 2NNX ; 2R27 ; 2V0A ; 2VR6 ; 2VR7 ; 2VR8 ; 2WKO ; 2WYT ; 2WYZ ; 2WZ0 ; 2WZ5 ; 2WZ6 ; 2XJK ; 2XJL ; 2ZKW ; 2ZKX ; 2ZKY ; 3CQP ; 3CQQ ; 3ECU ; 3ECV ; 3ECW ; 3GQF ; 3GTV ; 3GZO ; 3GZP ; 3GZQ ; 3H2P ; 3H2Q ; 3HFF ; 3K91 ; 3KH3 ; 3KH4 ; 3LTV ; 3QQD ; 3RE0 ; 3T5W ; 4A7G ; 4A7Q ; 4A7S ; 4A7T ; 4A7U ; 4A7V ; 4B3E ; 4BCY ; 4BCZ ; 4BD4 ; 4FF9 ; 4MCM ; 4MCN ; 4NIN ; 4NIO ; 4NIP ; 4OH2 ; 4XCR ; 5DLI ; 5IIW ; 5J07 ; 5J0C ; 5J0F ; 5J0G ; 5K02 ; 5O3Y ; 5O40 ; 5U9M ; 5WMJ ; 5WOR ; 5YTO ; 5YTU ; 5YUL ; 6A9O ; 6B79 ; 6DTK ; 6FFK ; 6FLH ; 6FOI ; 6FOL ; 6FON ; 6FP6 ; 6SPA ; 6SPH ; 6SPI ; 6SPJ ; 6SPK ; 6Z3V ; 6Z4G ; 6Z4H ; 6Z4I ; 6Z4J ; 6Z4K ; 6Z4L ; 6Z4M ; 6Z4O ; 7CJV ; 7CJW ; 7FB6 ; 7FB9 ; 7NXX ; 7T8E ; 7T8F ; 7T8G ; 7T8H ; 7VZF ; 8GSQ
EC Number
1.15.1.1
Pfam ID
PF00080
Sequence
MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTS
AGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVV
HEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
Function Destroys radicals which are normally produced within the cells and which are toxic to biological systems.
KEGG Pathway
Peroxisome (hsa04146 )
Longevity regulating pathway - multiple species (hsa04213 )
Parkinson disease (hsa05012 )
Amyotrophic lateral sclerosis (hsa05014 )
Huntington disease (hsa05016 )
Prion disease (hsa05020 )
Pathways of neurodegeneration - multiple diseases (hsa05022 )
Chemical carcinogenesis - reactive oxygen species (hsa05208 )
Reactome Pathway
Detoxification of Reactive Oxygen Species (R-HSA-3299685 )
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation (R-HSA-8950505 )
Platelet degranulation (R-HSA-114608 )
BioCyc Pathway
MetaCyc:HS06899-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Amyotrophic lateral sclerosis type 1 DIS5A2M0 Definitive Autosomal dominant [1]
Spastic tetraplegia and axial hypotonia, progressive DISJN89S Strong Autosomal recessive [2]
Amyotrophic lateral sclerosis DISF7HVM Supportive Autosomal dominant [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 8 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Cyclophosphamide DM4O2Z7 Approved Superoxide dismutase (SOD1) increases the Pulmonary toxicity ADR of Cyclophosphamide. [87]
Vinblastine DM5TVS3 Approved Superoxide dismutase (SOD1) affects the response to substance of Vinblastine. [88]
Haloperidol DM96SE0 Approved Superoxide dismutase (SOD1) increases the Orofacial dyskinesia ADR of Haloperidol. [87]
Amphetamine DMSZQAK Approved Superoxide dismutase (SOD1) decreases the response to substance of Amphetamine. [89]
Levodopa DMN3E57 Approved Superoxide dismutase (SOD1) affects the response to substance of Levodopa. [90]
Paraquat DMR8O3X Investigative Superoxide dismutase (SOD1) increases the response to substance of Paraquat. [91]
PATULIN DM0RV9C Investigative Superoxide dismutase (SOD1) decreases the response to substance of PATULIN. [92]
Methylenedioxymethamphetamine DMYVU47 Investigative Superoxide dismutase (SOD1) affects the response to substance of Methylenedioxymethamphetamine. [93]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
92 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Superoxide dismutase (SOD1). [4]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Superoxide dismutase (SOD1). [5]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Superoxide dismutase (SOD1). [6]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Superoxide dismutase (SOD1). [7]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Superoxide dismutase (SOD1). [8]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Superoxide dismutase (SOD1). [9]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Superoxide dismutase (SOD1). [10]
Arsenic DMTL2Y1 Approved Arsenic increases the expression of Superoxide dismutase (SOD1). [11]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Superoxide dismutase (SOD1). [12]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Superoxide dismutase (SOD1). [13]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide decreases the expression of Superoxide dismutase (SOD1). [14]
Triclosan DMZUR4N Approved Triclosan affects the expression of Superoxide dismutase (SOD1). [15]
Methotrexate DM2TEOL Approved Methotrexate increases the expression of Superoxide dismutase (SOD1). [16]
Fulvestrant DM0YZC6 Approved Fulvestrant increases the expression of Superoxide dismutase (SOD1). [17]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of Superoxide dismutase (SOD1). [18]
Hydroquinone DM6AVR4 Approved Hydroquinone decreases the expression of Superoxide dismutase (SOD1). [19]
Rosiglitazone DMILWZR Approved Rosiglitazone increases the expression of Superoxide dismutase (SOD1). [20]
Irinotecan DMP6SC2 Approved Irinotecan increases the expression of Superoxide dismutase (SOD1). [21]
Diclofenac DMPIHLS Approved Diclofenac increases the expression of Superoxide dismutase (SOD1). [16]
Nicotine DMWX5CO Approved Nicotine decreases the expression of Superoxide dismutase (SOD1). [22]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate increases the expression of Superoxide dismutase (SOD1). [23]
Clozapine DMFC71L Approved Clozapine decreases the expression of Superoxide dismutase (SOD1). [24]
DTI-015 DMXZRW0 Approved DTI-015 decreases the activity of Superoxide dismutase (SOD1). [25]
Indomethacin DMSC4A7 Approved Indomethacin increases the expression of Superoxide dismutase (SOD1). [16]
Menthol DMG2KW7 Approved Menthol increases the expression of Superoxide dismutase (SOD1). [26]
Mitomycin DMH0ZJE Approved Mitomycin increases the expression of Superoxide dismutase (SOD1). [27]
Cocaine DMSOX7I Approved Cocaine decreases the expression of Superoxide dismutase (SOD1). [28]
Methamphetamine DMPM4SK Approved Methamphetamine increases the activity of Superoxide dismutase (SOD1). [29]
Pioglitazone DMKJ485 Approved Pioglitazone increases the expression of Superoxide dismutase (SOD1). [30]
Liothyronine DM6IR3P Approved Liothyronine decreases the expression of Superoxide dismutase (SOD1). [31]
Vitamin C DMXJ7O8 Approved Vitamin C increases the expression of Superoxide dismutase (SOD1). [32]
Beta-carotene DM0RXBT Approved Beta-carotene decreases the expression of Superoxide dismutase (SOD1). [33]
Dihydroartemisinin DMBXVMZ Approved Dihydroartemisinin increases the expression of Superoxide dismutase (SOD1). [34]
Bosentan DMIOGBU Approved Bosentan decreases the expression of Superoxide dismutase (SOD1). [37]
Bezafibrate DMZDCS0 Approved Bezafibrate increases the expression of Superoxide dismutase (SOD1). [30]
Adenosine triphosphate DM79F6G Approved Adenosine triphosphate increases the expression of Superoxide dismutase (SOD1). [38]
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Approved Eicosapentaenoic acid/docosa-hexaenoic acid decreases the expression of Superoxide dismutase (SOD1). [39]
Penicillamine DM40EF6 Approved Penicillamine decreases the activity of Superoxide dismutase (SOD1). [40]
Bleomycin DMNER5S Approved Bleomycin increases the expression of Superoxide dismutase (SOD1). [41]
Clofibrate DMPC1J7 Approved Clofibrate decreases the expression of Superoxide dismutase (SOD1). [39]
Epinephrine DM3KJBC Approved Epinephrine increases the expression of Superoxide dismutase (SOD1). [43]
Gallium nitrate DMF9O6B Approved Gallium nitrate decreases the expression of Superoxide dismutase (SOD1). [44]
Tolcapone DM8MNVO Approved Tolcapone decreases the expression of Superoxide dismutase (SOD1). [45]
Trientine DMD2WPG Approved Trientine decreases the activity of Superoxide dismutase (SOD1). [46]
Aclarubicin DMLFZHD Approved Aclarubicin decreases the activity of Superoxide dismutase (SOD1). [47]
Piperazine DMTY9LU Approved Piperazine increases the activity of Superoxide dismutase (SOD1). [48]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Superoxide dismutase (SOD1). [49]
Resveratrol DM3RWXL Phase 3 Resveratrol increases the expression of Superoxide dismutase (SOD1). [50]
Epigallocatechin gallate DMCGWBJ Phase 3 Epigallocatechin gallate decreases the expression of Superoxide dismutase (SOD1). [51]
Curcumin DMQPH29 Phase 3 Curcumin increases the expression of Superoxide dismutase (SOD1). [52]
Fenretinide DMRD5SP Phase 3 Fenretinide increases the expression of Superoxide dismutase (SOD1). [53]
Camptothecin DM6CHNJ Phase 3 Camptothecin increases the expression of Superoxide dismutase (SOD1). [54]
Coprexa DMA0WEK Phase 3 Coprexa decreases the expression of Superoxide dismutase (SOD1). [40]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Superoxide dismutase (SOD1). [55]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone decreases the expression of Superoxide dismutase (SOD1). [56]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Superoxide dismutase (SOD1). [57]
DNCB DMDTVYC Phase 2 DNCB increases the expression of Superoxide dismutase (SOD1). [58]
phorbol 12-myristate 13-acetate DMJWD62 Phase 2 phorbol 12-myristate 13-acetate decreases the expression of Superoxide dismutase (SOD1). [59]
Disulfiram DMCL2OK Phase 2 Trial Disulfiram increases the expression of Superoxide dismutase (SOD1). [58]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Superoxide dismutase (SOD1). [61]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Superoxide dismutase (SOD1). [62]
Mivebresib DMCPF90 Phase 1 Mivebresib increases the expression of Superoxide dismutase (SOD1). [63]
Aminoguanidine DMJQDUC Phase 1 Aminoguanidine decreases the expression of Superoxide dismutase (SOD1). [64]
Eugenol DM7US1H Patented Eugenol decreases the expression of Superoxide dismutase (SOD1). [66]
Flavonoid derivative 1 DMCQP0B Patented Flavonoid derivative 1 increases the expression of Superoxide dismutase (SOD1). [21]
Undecylenic acid derivative 1 DMLJ2HE Patented Undecylenic acid derivative 1 increases the expression of Superoxide dismutase (SOD1). [23]
MG-132 DMKA2YS Preclinical MG-132 decreases the expression of Superoxide dismutase (SOD1). [67]
MANUMYCIN A DM1SWOY Terminated MANUMYCIN A decreases the expression of Superoxide dismutase (SOD1). [68]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Superoxide dismutase (SOD1). [69]
Sulforaphane DMQY3L0 Investigative Sulforaphane increases the expression of Superoxide dismutase (SOD1). [70]
chloropicrin DMSGBQA Investigative chloropicrin increases the expression of Superoxide dismutase (SOD1). [71]
3R14S-OCHRATOXIN A DM2KEW6 Investigative 3R14S-OCHRATOXIN A increases the expression of Superoxide dismutase (SOD1). [72]
Glyphosate DM0AFY7 Investigative Glyphosate decreases the expression of Superoxide dismutase (SOD1). [59]
Nickel chloride DMI12Y8 Investigative Nickel chloride increases the expression of Superoxide dismutase (SOD1). [73]
Hexadecanoic acid DMWUXDZ Investigative Hexadecanoic acid decreases the expression of Superoxide dismutase (SOD1). [74]
D-glucose DMMG2TO Investigative D-glucose decreases the expression of Superoxide dismutase (SOD1). [75]
AHPN DM8G6O4 Investigative AHPN decreases the expression of Superoxide dismutase (SOD1). [76]
Butanoic acid DMTAJP7 Investigative Butanoic acid affects the activity of Superoxide dismutase (SOD1). [47]
Okadaic acid DM47CO1 Investigative Okadaic acid decreases the expression of Superoxide dismutase (SOD1). [77]
Cordycepin DM72Y01 Investigative Cordycepin decreases the expression of Superoxide dismutase (SOD1). [78]
Lead acetate DML0GZ2 Investigative Lead acetate increases the expression of Superoxide dismutase (SOD1). [79]
Kaempferol DMHEMUB Investigative Kaempferol increases the expression of Superoxide dismutase (SOD1). [70]
(E)-4-(3,5-dimethoxystyryl)phenol DMYXI2V Investigative (E)-4-(3,5-dimethoxystyryl)phenol increases the expression of Superoxide dismutase (SOD1). [70]
Oleic acid DM54O1Z Investigative Oleic acid decreases the expression of Superoxide dismutase (SOD1). [80]
Uric acid DMA1MKT Investigative Uric acid affects the activity of Superoxide dismutase (SOD1). [81]
Pyrrolidine dithiocarbamate DM5ZAS6 Investigative Pyrrolidine dithiocarbamate decreases the expression of Superoxide dismutase (SOD1). [82]
methylglyoxal DMRC3OZ Investigative methylglyoxal decreases the expression of Superoxide dismutase (SOD1). [83]
Icosapentum DMF1CM7 Investigative Icosapentum increases the expression of Superoxide dismutase (SOD1). [30]
Phenanthrene-9,10-dione DMG8KS9 Investigative Phenanthrene-9,10-dione decreases the expression of Superoxide dismutase (SOD1). [85]
GW7604 DMCA4RM Investigative GW7604 increases the expression of Superoxide dismutase (SOD1). [17]
ROSMARINIC ACID DMQ6SJT Investigative ROSMARINIC ACID increases the expression of Superoxide dismutase (SOD1). [79]
Lefaxin DM0CEY3 Investigative Lefaxin affects the expression of Superoxide dismutase (SOD1). [86]
------------------------------------------------------------------------------------
⏷ Show the Full List of 92 Drug(s)
7 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
Dopamine DMPGUCF Approved Dopamine affects the binding of Superoxide dismutase (SOD1). [35]
Nitric Oxide DM1RBYG Approved Nitric Oxide decreases the response to substance of Superoxide dismutase (SOD1). [36]
Isoproterenol DMK7MEY Approved Isoproterenol affects the binding of Superoxide dismutase (SOD1). [35]
Fructose DM43AN2 Approved Fructose affects the binding of Superoxide dismutase (SOD1). [42]
SPI-1005 DM6XFHS Phase 2 Trial SPI-1005 decreases the response to substance of Superoxide dismutase (SOD1). [60]
1,4-Dithiothreitol DMIFOXE Investigative 1,4-Dithiothreitol affects the folding of Superoxide dismutase (SOD1). [84]
Guanidine DM4GO8H Investigative Guanidine decreases the folding of Superoxide dismutase (SOD1). [35]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 increases the phosphorylation of Superoxide dismutase (SOD1). [65]
------------------------------------------------------------------------------------

References

1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
2 Phenotype in an Infant with SOD1 Homozygous Truncating Mutation. N Engl J Med. 2019 Aug 1;381(5):486-488. doi: 10.1056/NEJMc1905039. Epub 2019 Jul 17.
3 Amyotrophic Lateral Sclerosis Overview. 2001 Mar 23 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(?) [Internet]. Seattle (WA): University of Washington, Seattle; 1993C2024.
4 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
5 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
6 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
7 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
8 Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm. 2006 Mar-Apr;3(2):113-23.
9 Poly(ADP-ribose) polymerase 1 contributes to oxidative stress through downregulation of sirtuin 3 during cisplatin nephrotoxicity. Anat Cell Biol. 2016 Sep;49(3):165-176. doi: 10.5115/acb.2016.49.3.165. Epub 2016 Sep 29.
10 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
11 Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci. 2001 Jan;59(1):185-92.
12 Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005 Sep;4(9):949-55.
13 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
14 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
15 The modulatory effect of triclosan on the reversion of the activated phenotype of LX-2 hepatic stellate cells. J Biochem Mol Toxicol. 2020 Jan;34(1):e22413. doi: 10.1002/jbt.22413. Epub 2019 Nov 12.
16 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
17 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
18 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
19 Hydroquinone-induced apoptosis in HL-60 cells. Anticancer Res. 2005 Jan-Feb;25(1A):161-70.
20 Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. Toxicol Appl Pharmacol. 2022 May 1;442:115991. doi: 10.1016/j.taap.2022.115991. Epub 2022 Mar 23.
21 The PPAR-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells. Chem Biol Interact. 2022 Jan 5;351:109712. doi: 10.1016/j.cbi.2021.109712. Epub 2021 Oct 23.
22 Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. FASEB J. 2006 Jun;20(8):1212-4.
23 Identification of potential biomarkers for predicting acute dermal irritation by proteomic analysis. J Appl Toxicol. 2011 Nov;31(8):762-72.
24 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
25 Proline analogue of nitrosourea as a new cytotoxic prodrug. Arch Pharm (Weinheim). 2009 Nov;342(11):632-9.
26 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
27 Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment. Mutat Res. 2008 Oct 30;656(1-2):1-7.
28 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
29 Brain antioxidant systems in human methamphetamine users. J Neurochem. 2004 Jun;89(6):1396-408.
30 The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism. 2001 Jan;50(1):3-11.
31 Negative regulation of superoxide dismutase-1 promoter by thyroid hormone. Mol Pharmacol. 2006 Sep;70(3):793-800.
32 Galbanic acid: Induced antiproliferation in estrogen receptor-negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts. J Biochem Mol Toxicol. 2019 Nov;33(11):e22402. doi: 10.1002/jbt.22402. Epub 2019 Oct 1.
33 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
34 Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers. Chem Biol Interact. 2010 Jun 7;186(1):30-5.
35 Ligand binding and aggregation of pathogenic SOD1. Nat Commun. 2013;4:1758. doi: 10.1038/ncomms2750.
36 Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J Neurochem. 2010 Jan;112(1):183-92. doi: 10.1111/j.1471-4159.2009.06441.x. Epub 2009 Oct 20.
37 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
38 Involvement of P2Y receptors in the protective effect of ATP towards the cell damage in HaCaT cells exposed to H? J Toxicol Sci. 2011;36(6):741-50.
39 Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol. 2009 Sep;76(3):588-95.
40 Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvasc Res. 2009 May;77(3):314-26.
41 Age-dependent basal level and induction capacity of copper-zinc and manganese superoxide dismutase and other scavenging enzyme activities in leukocytes from young and elderly adults. Am J Pathol. 1993 Jul;143(1):312-20.
42 Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis. FASEB J. 2003 May;17(8):938-40. doi: 10.1096/fj.02-0768fje. Epub 2003 Mar 5.
43 Epinephrine upregulates superoxide dismutase in human coronary artery endothelial cells. Free Radic Biol Med. 2001 Jan 15;30(2):148-53.
44 Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells. Free Radic Biol Med. 2008 Sep 15;45(6):763-72.
45 The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells. Toxicol In Vitro. 2017 Aug;42:337-347.
46 Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis. Free Radic Biol Med. 2001 May 15;30(10):1177-87.
47 Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radic Biol Med. 2000 Jan 1;28(1):18-27.
48 Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine. Toxicol Mech Methods. 2018 Mar;28(3):177-186. doi: 10.1080/15376516.2017.1376024. Epub 2017 Sep 28.
49 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
50 Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol. 2009 Oct;60 Suppl 4:111-6.
51 Low dose epigallocatechin-3-gallate revives doxorubicin responsiveness by a redox-sensitive pathway in A549 lung adenocarcinoma cells. J Biochem Mol Toxicol. 2022 Apr;36(4):e22999. doi: 10.1002/jbt.22999. Epub 2022 Feb 26.
52 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
53 Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress. Neoplasia. 2014 Sep;16(9):710-22.
54 Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes. Environ Toxicol. 2019 Apr;34(4):401-414.
55 A high-throughput reporter gene assay to prove the ability of natural compounds to modulate glutathione peroxidase, superoxide dismutase and catalase gene promoters in V79 cells. Free Radic Res. 2008 Aug;42(8):746-53.
56 Study on Protection of Human Umbilical Vein Endothelial Cells from Amiodarone-Induced Damage by Intermedin through Activation of Wnt/-Catenin Signaling Pathway. Oxid Med Cell Longev. 2021 Aug 14;2021:8889408. doi: 10.1155/2021/8889408. eCollection 2021.
57 Alpha-tocopherol modulates human umbilical vein endothelial cell expression of Cu/Zn superoxide dismutase and catalase and lipid peroxidation. Nutr Res. 2008 Oct;28(10):671-80.
58 Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicol Sci. 2010 Sep;117(1):81-9.
59 Emptying of intracellular calcium pool and oxidative stress imbalance are associated with the glyphosate-induced proliferation in human skin keratinocytes HaCaT cells. ISRN Dermatol. 2013 Aug 29;2013:825180.
60 Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain. 2006 Jul;129(Pt 7):1693-709. doi: 10.1093/brain/awl118. Epub 2006 May 15.
61 Early changes in proteome levels upon acute deltamethrin exposure in mammalian skin system associated with its neoplastic transformation potential. J Toxicol Sci. 2013;38(4):629-42.
62 The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene. 2016 Feb 18;35(7):833-45.
63 Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells. Blood Cancer J. 2019 Jan 15;9(2):4. doi: 10.1038/s41408-018-0165-5.
64 Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice. World J Gastroenterol. 2009 Mar 7;15(9):1065-71.
65 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
66 Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression by eugenol-related compounds. Anticancer Res. 2005 Sep-Oct;25(5):3263-9.
67 The role of PSMB5 in sodium arsenite-induced oxidative stress in L-02 cells. Cell Stress Chaperones. 2020 May;25(3):533-540. doi: 10.1007/s12192-020-01104-1. Epub 2020 Apr 16.
68 Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation. Free Radic Biol Med. 2009 Aug 15;47(4):364-74.
69 Bisphenol A modulates inflammation and proliferation pathway in human endometrial stromal cells by inducing oxidative stress. Reprod Toxicol. 2018 Oct;81:41-49.
70 The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem Toxicol. 2014 Oct;72:303-11.
71 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
72 Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. Toxicol Appl Pharmacol. 2013 Apr 15;268(2):123-31.
73 Cancer stem-like cells accumulated in nickel-induced malignant transformation. Toxicol Sci. 2016 Jun;151(2):376-87.
74 PPARgamma-dependent and -independent effects of rosiglitazone on lipotoxic human pancreatic islets. Biochem Biophys Res Commun. 2008 Feb 22;366(4):1096-101. doi: 10.1016/j.bbrc.2007.12.088. Epub 2007 Dec 26.
75 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
76 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
77 Evaluation of okadaic acid toxicity in human retinal cells and zebrafish retinas. Toxicology. 2022 May 15;473:153209. doi: 10.1016/j.tox.2022.153209. Epub 2022 May 13.
78 Cordycepin induces apoptotic cell death of human brain cancer through the modulation of autophagy. Toxicol In Vitro. 2018 Feb;46:113-121.
79 Identification of lead-produced lipid hydroperoxides in human HepG2 cells and protection using rosmarinic and ascorbic acids with a reference to their regulatory roles on Nrf2-Keap1 antioxidant pathway. Chem Biol Interact. 2019 Dec 1;314:108847. doi: 10.1016/j.cbi.2019.108847. Epub 2019 Oct 11.
80 Gastrodin ameliorates oxidative stress and proinflammatory response in nonalcoholic fatty liver disease through the AMPK/Nrf2 pathway. Phytother Res. 2016 Mar;30(3):402-11.
81 Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans. Biol Trace Elem Res. 2000 Jan;73(1):55-65.
82 Effects of a redox-active agent on lymphocyte activation and early gene expression patterns. Free Radic Biol Med. 2004 Nov 15;37(10):1550-63.
83 Methylglyoxal disturbs the expression of antioxidant, apoptotic and glycation responsive genes and triggers programmed cell death in human leukocytes. Toxicol In Vitro. 2019 Mar;55:33-42.
84 Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis. J Biol Chem. 2016 Feb 19;291(8):4144-55. doi: 10.1074/jbc.M115.683763. Epub 2015 Dec 22.
85 9,10-Phenanthraquinone in diesel exhaust particles downregulates Cu,Zn-SOD and HO-1 in human pulmonary epithelial cells: intracellular iron scavenger 1,10-phenanthroline affords protection against apoptosis. Free Radic Biol Med. 2005 Feb 1;38(3):388-95.
86 The Val16Ala-SOD2 polymorphism affects cyto-genotoxicity of pyridostigmine bromide on human peripheral blood mononuclear cells. Toxicol In Vitro. 2019 Oct;60:237-244.
87 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
88 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
89 Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation. Neuroscience. 2001;107(2):265-74. doi: 10.1016/s0306-4522(01)00351-7.
90 Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem. 1997 Jul;69(1):21-33. doi: 10.1046/j.1471-4159.1997.69010021.x.
91 Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet. 2001 Sep 15;10(19):2013-23. doi: 10.1093/hmg/10.19.2013.
92 Induction of oxidative stress response by the mycotoxin patulin in mammalian cells. Toxicol Sci. 2007 Feb;95(2):340-7. doi: 10.1093/toxsci/kfl156. Epub 2006 Nov 7.
93 Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne (Paris). 2001 Apr;152 Suppl 3:IS57-9.